No abstract available
Keywords:
cancer therapy; epigenetics; histone deacetylases; inhibitors; prognostic biomarker; tumor microenvironment.
Grants and funding
ÂS was supported by CICS-UBI projects UIDB/00709/2020 and UIDP/00709/2020, financed by national funds through the Portuguese Foundation for Science and Technology/MCTES. CC is supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) PROC. 2019/10746-6 and National Council for Scientific and Technological Development (CNPq) for productivity fellowship level 2 (CNPq process 306009/2022-6). DT was supported by Banca d’Italia Contributo liberale 2021and AIRCprojects under IG 2020-ID 24942.